Skip to main content

Keratitis News

Corticosteroids Not Superior to Placebo for Add-On Treatment of Bacterial Keratitis

MONDAY, July 28, 2025 – For the treatment of bacterial keratitis, adjunctive corticosteroids are not superior to placebo and adjunctive corneal cross-linking (CXL) is associated with increased scar...

Microbial Keratitis Outcomes Affected by Delays in Presentation, Disease Severity

WEDNESDAY, April 30, 2025 – For patients with microbial keratitis (MK), initial vision, longer time to presentation, and larger stromal infiltrate size lead to a higher risk for worse 90-day...

FDA Approves Oxervate (cenegermin) for Neurotrophic Keratitis

August 22, 2018 – The U.S. Food and Drug Administration today approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea (the...

Sirion Therapeutics Announces FDA Approval of Zirgan (ganciclovir ophthalmic gel) 0.15% for Herpetic Keratitis

TAMPA, FL, September 16, 2009 – Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has approved i...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related drug support groups

prednisone, triamcinolone, cortisone, dexamethasone